Brazil's health ministry said on Sunday it will sign non-binding letters of intent to purchase coronavirus vaccines from four companies and Russia's sovereign wealth fund, adding that any purchase will depend on the approval of the nation's regulators.17 comments
US drugmaker Pfizer Inc is hoping to rapidly roll out its experimental COVID-19 vaccine around Latin America soon after it gets emergency authorization in the United States, a senior executive said, which could be as early as next month.Add your comment!
The U.S. Food and Drug Administration's outside advisers will meet on Dec. 10 to discuss whether to authorize the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday.Add your comment!
The United States' top infectious disease official said that two coronavirus vaccines being tested were solid, and that the speed at which they were developed has not compromised safety or integrity.Add your comment!
Pfizer Inc said on Wednesday it had offered to provide Brazil with millions of doses of a COVID-19 vaccine in the first half of 2021, amid evidence the coronavirus is spreading more rapidly in South America's largest country.Add your comment!
Europe's leading stock exchanges traded steadily on Tuesday after Monday's euphoria when they were boosted by the announcement of the Pfizer-BioNTech vaccine, which is 90% effective thanks to a new technology called 'Messenger Ribonucleic Acid' or messenger RNA.
Argentina President Alberto Fernandez said on Friday his country could receive 750,000 doses of an eventual coronavirus vaccine from U.S. drugmaker Pfizer Inc in December, a glimmer of hope as cases in the South American nation show signs of receding following months of quarantine.
US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn in what is the biggest pharmaceuticals deal in history. The takeover could allow Pfizer to escape relatively high US corporate tax rates by moving its headquarters to Allergan's Dublin base.
US drug-maker Pfizer has agreed to pay 491 million dollars to settle a probe into illegal marketing of a drug by Wyeth, a firm it had acquired in 2009. The case revolved around Rapamune, a drug prescribed to prevent rejection of transplanted kidneys.
Brazil's High Court of Justice ruled Wednesday that the Brazilian patent for the drug Viagra is due to expire June 20.